BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1997392)

  • 1. Type III hyperlipoproteinemia in a patient with idiopathic hemochromatosis.
    Feussner G; Ziegler R
    Hum Genet; 1991 Jan; 86(3):326-8. PubMed ID: 1997392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Type III hyperlipoproteinemia in idiopathic hemochromatosis].
    Feussner G; Ziegler R
    Klin Wochenschr; 1990; 68 Suppl 22():100-1. PubMed ID: 2087060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational hyperlipidemic pancreatitis caused by type III hyperlipoproteinemia with apolipoprotein E2/E2 homozygote.
    Chuang TY; Chao CL; Lin BJ; Lu SC
    Pancreas; 2009 Aug; 38(6):716-7. PubMed ID: 19629007
    [No Abstract]   [Full Text] [Related]  

  • 4. Histocompatibility antigens as markers of abnormal iron metabolism in idiopathic hemochromatosis.
    Lloyd DA; Adams P; Sinclair NR; Stiller CR; Valberg LS
    Can Med Assoc J; 1978 Nov; 119(9):1051-6. PubMed ID: 84705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HLA-linked hemochromatosis with idiopathic refractory sideroblastic anemia.
    Cartwright GE; Edwards CQ; Skolnick MH; Amos DB
    J Clin Invest; 1980 May; 65(5):989-92. PubMed ID: 7364949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical expression of the genetic abnormality in idiopathic hemochromatosis.
    Valberg LS; Lloyd DA; Ghent CN; Flanagan PR; Sinclair NR; Stiller CR; Chamberlain MJ
    Gastroenterology; 1980 Nov; 79(5 Pt 1):884-92. PubMed ID: 7419013
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiopathic hemochromatosis: demonstration of homozygous-heterozygous mating by HLA typing of families.
    Bassett ML; Doran TJ; Halliday JW; Bashir HV; Powell LW
    Hum Genet; 1982; 60(4):352-6. PubMed ID: 7106771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on hereditary hemochromatosis and the HFE gene.
    Brandhagen DJ; Fairbanks VF; Batts KP; Thibodeau SN
    Mayo Clin Proc; 1999 Sep; 74(9):917-21. PubMed ID: 10488796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.
    Okubo M; Aoyama Y; Harada K; Fukawa M; Tsukada T; Mokuno H; Yamada N; Murase T
    Atherosclerosis; 1998 Sep; 140(1):187-90. PubMed ID: 9733231
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload.
    Fargion S; Cappellini MD; Piperno A; Panajotopoulos N; Ronchi G; Fiorelli G
    Am J Clin Pathol; 1986 Nov; 86(5):645-9. PubMed ID: 3776916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic hemochromatosis: a study of biochemical expression in 247 heterozygous members of 63 families: evidence for a single major HLA-linked gene.
    Simon M; Fauchet R; Hespel JP; Beaumont C; Brissot P; Hery B; Hita De Nercy Y; Genetet B; Bourel M
    Gastroenterology; 1980 Apr; 78(4):703-8. PubMed ID: 7353757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dyslipidemia and accelerated atherosclerosis.
    Hazzard WR
    Hosp Pract (Off Ed); 1988 May; 23(5A):41-50. PubMed ID: 2967303
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hereditary hemochromatosis].
    Dantas W
    Rev Gastroenterol Peru; 2001; 21(1):42-55. PubMed ID: 12170286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disappearance of angina pectoris by lipid-lowering in type III hyperlipoproteinemia.
    Cho EJ; Min YJ; Oh MS; Kwon JE; Kim JE; Kim CJ
    Am J Cardiol; 2011 Mar; 107(5):793-6. PubMed ID: 21247547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 17. Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis.
    Pérez de Nanclares G; Castaño L; Gaztambide S; Bilbao JR; Pi J; González ML; Vázquez JA
    N Engl J Med; 2000 Sep; 343(12):891. PubMed ID: 11001697
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron overload in three generations of a family with hemoglobin Olympia.
    Weaver GA; Rahbar S; Ellsworth CA; de Alarcon PA; Forbes GB; Beutler E
    Gastroenterology; 1984 Sep; 87(3):695-702. PubMed ID: 6745619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary hemochromatosis: recent advances in molecular genetics and clinical management.
    Camaschella C; Piperno A
    Haematologica; 1997; 82(1):77-84. PubMed ID: 9107091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Idiopathic hemochromatosis in an HLA-A3 heterozygote].
    Lund BV; Jensen HH; Nørredam JC; Grunnet N
    Ugeskr Laeger; 1988 Aug; 150(34):2040-1. PubMed ID: 3261911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.